Clinical Trials in Baotou, Inner Mongolia

9 recruiting

Showing 18 of 8 trials

Recruiting
Phase 3

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

ObesityHeart Failure With Preserved Ejection FractionHeart Failure With Mildly Reduced Ejection Fraction
Amgen5,056 enrolled564 locationsNCT07037459
Recruiting
Phase 2

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

Asthma
Pfizer252 enrolled125 locationsNCT06977581
Recruiting
Phase 3

Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A)

Alzheimer s Disease
Danyang Huichuang Medical Equipment Co., Ltd.320 enrolled23 locationsNCT07262645
Recruiting
Phase 2

Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer

Extensive-stage Small-cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.134 enrolled28 locationsNCT06897579
Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy

Melanoma
Innovent Biologics (Suzhou) Co. Ltd.180 enrolled31 locationsNCT06797297
Recruiting
Phase 3

TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

Asthma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.660 enrolled74 locationsNCT06829784
Recruiting

TESTING -ON Post-Trial ObservatioNal Cohort Study

Kidney DiseasesIgA NephropathyGlomerulonephritis+1 more
The George Institute366 enrolled58 locationsNCT05434325
Recruiting
Phase 4

Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3

Renal Insufficiency, Chronic
The First Affiliated Hospital of Dalian Medical University466 enrolled34 locationsNCT04263922